AC
Andy Chen Wolfe Research Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
38.9%
Neutral
61.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 7 Jan ‘26 2 months ago |
|
|
|
Outperform
Upgraded
| $50 |
94%
upside
| 1 | +3% |
0
%
| 6 Jan ‘26 2 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | – |
–
| 6 Jan ‘26 2 months ago |
|
|
|
Outperform
Upgraded
| $548 |
10%
upside
| 1 | +11% |
0
%
| 6 Jan ‘26 2 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | +51% |
–
| 24 Nov ‘25 3 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 2 | +41% |
0
%
| 12 Nov ‘25 3 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 6 Nov ‘25 4 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | – |
–
| 10 Oct ‘25 5 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | +61% |
–
| 19 Sep ‘25 5 months ago |
|
|
|
Peer Perform
Upgraded
| – | – | 1 | -44% |
–
| 4 Aug ‘25 7 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | -43% |
–
| 4 Aug ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $170 | – | 1 | +13% |
0
%
| 1 Jul ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $49 |
34%
downside
| 1 | +81% |
0
%
| 17 Jun ‘25 8 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 17 Jun ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $55 | – | 1 | +144% |
0
%
| 17 Jun ‘25 8 months ago |
|
|
|
Peer Perform
Downgraded
| – | – | 1 | – |
–
| 3 Jun ‘25 9 months ago |
|
|
|
Outperform
Upgraded
| $61 |
233%
upside
| 1 | -51% |
0
%
| 19 May ‘25 9 months ago |
|